This study also suggested that, while increasing HDL-cholesterol level, inhibition of serum CETP activity leads to metabolic dysregulation such as fatty liver, insulin resistance, and inflammation (Zhu et al., 2018a). The gene discussed is CETP; the disease is Insulin resistance.